Maxx Matrix Surgical Amnion
Maxx Matrix is a family of amnion patch allografts that may be used as an anatomical barrier in numerous surgical applications. The natural properties of amniotic tissue help provide mechanical protection to damaged tissue, while the Maxx Matrix proprietary process retains nutrient-rich growth factors essential for signaling.
DUAL-LAYER
Two layers of amniotic tissue provides 2x the growth factors
EASY TO USE
Thicker graft facilitates handling in robotic and laparoscopic surgical process
SURGICAL BARRIER
Designed for scar tissue and inflammation reduction potential
EASY PLACEMENT
Dual layer allows placement of the graft on either side, eliminating orientation restrictions in surgical repair
CHORION FREE
Immune privileged, reducing the risk of adverse responses
SURGICAL BARRIER
Offers greater tensile strength, shape manipulation and slower resorption in vivo
Potential Benefits of Amniotic Membrane Growth Factors:3*
- Non-Immunogenic
- Anti-bacterial
- Anti-inflammatory
- Tissue regeneration/remodeling
- Anti-adhesive/anti-scarring
- Anti-microbial
The placenta contains growth factors and proteins that stimulate the body’s own healing mechanism, reducing pain, inammation, and scar tissue4
- Platelet Derived Growth Factor (PDGF) A & B
- Transforming Growth Factor beta (TGFβ)
- Epidermal Growth Factor (EGF)
- Collagen Types I, III, IV, V, VII
- Fibronectin
- Hyaluronic Acid (HA)
- Vascular Endothelial Growth Factor (VEGF)
- Fibroblast Growth Factor (FGF)
- Tissue Inhibitors of Metalloproteinases (TIMPs)
- Laminin
- Proteoglycans
Tissue Recovery & Processing
Amniotic Membranes are donated by healthy, pre-screened, consenting women in the US, and processed in accordance with
TISSUE COLLECTION
Placental tissue is donated from live births in the U.S. without harming the mother or baby
DONOR SCREENING
A thorough medical and social history is obtained for each donor to ensure eligibility requirements are met
INFECTIOUS DISEASE TESTING
- HBsAg
- HBcAb
- HCVAb
- RPR/STS
- WNV NAT
- HCV NAT
- HBV NAT
- HIV NAT
- HIV 1/2Ab
- HTLV I/II Ab
TISSUE PROCESSING
All tissue undergoes a proprietary cleansing process to remove blood contaminants and reduce bioburden
TISSUE STERILIZATION
Tissue is sterilized for an additional level of safety, achieving a sterility assurance level (SAL) of 10-6
- Sinno, Prakash. Plast Surg Int. 2013:146764.
- Spoerl, et al. Ophthalmic Res. 2004;36(2):71-7
- Martin, et al. Encyclopedia of Reproduction, 2018;3:387-398.
- Mamede, et al. Cell Tissue Res. 2012, 349:447–458.
*Based on published studies; not specic to PalinGen Amniotic Membranes
| Product Description | Size | Product Code |
|---|---|---|
| Q4239 Maxx Matrix Membrane Dual Layer | 2cm x 2cm | AMM-22 |
| Q4239 Maxx Matrix Membrane Dual Layer | 2cm x 4cm | AMM-24 |
| Q4239 Maxx Matrix Membrane Dual Layer | 4cm x 4cm | AMM-44 |
| Q4239 Maxx Matrix Membrane Dual Layer | 4cm x 8cm | AMM-48 |
Explore our Entire Product Line
Autologous Advanced Biologics
Advanced Synthetics
About Royal
Royal is a pioneering leader in orthobiologic and wound care research and development. Royal’s commitment lies in delivering top-tier, innovative biologic solutions that enhance the healing process and improve patients' quality of life. Royal places patient well-being at the center of its mission, offering exceptional solutions to address a variety of complex needs.
At Royal, our mission is driven by patient-centered care, innovation and excellence, and integrity and compassion. Royal provides a comprehensive array of products tailored to meet the varied needs of the orthobiologic and wound care industry.
As a rapidly expanding force in the industry, Royal is continuously developing and launching new products and solutions that set benchmarks for quality, effectiveness, and patient outcomes. Royal’s commitment to research and innovation keeps it at the forefront of the industry, helping to shape the future of healthcare and improving lives.